PMDA drug package insert
テリルジー100エリプタ14吸入用
PMDA Prescription drug · グラクソ・スミスクライン株式会社 · package insert Aug 26, 2025
Key facts
| Brand names | テリルジー100エリプタ14吸入用, テリルジー100エリプタ30吸入用, テリルジー200エリプタ14吸入用, テリルジー200エリプタ30吸入用 |
|---|---|
| Nonproprietary names | フルチカゾンフランカルボン酸エステル・ウメクリジニウム臭化物・ビランテロールトリフェニル酢酸塩 |
| Companies | 製造販売元／グラクソ・スミスクライン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 3成分配合喘息・COPD治療剤; 3成分配合喘息治療剤 |
| Therapeutic category codes | 87229 |
| YJ codes | 2290804G1022, 2290804G2029, 2290804G3025, 2290804G4021 |
| Approval numbers | 23100AMX00294, 23100AMX00295, 30200AMX00956, 30200AMX00955 |
| Package insert edition | 第5版 |
| Package insert date | Aug 26, 2025 |
| PMDA document key | 340278_2290804G1022_1 |
| PMDA company code | 340278 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: